Log In Sign up
The largest database of trusted experimental protocols

Thioridazine

Manufactured by Cayman Chemical
Visit Supplier
Sourced in United States

Thioridazine is a laboratory standard provided by Cayman Chemical. It is a phenothiazine derivative with chemical formula C21H26N2S. Thioridazine is used as a reference standard in various analytical and research applications.

Automatically generated - may contain errors

Lab products found in correlation

Np ficoll, by Biosearch Technologies (2 mentions) Etomoxir, by Cayman Chemical (2 mentions) Quinpirole, by Bio-Techne (1 mentions) Aripiprazole, by Bio-Techne (1 mentions) Haloperidol, by Bio-Techne (1 mentions) A 769662, by LC Laboratories (1 mentions) Gammacell 3000, by Nordion (1 mentions) Cetrimonium bromide, by Merck Group (1 mentions) Ciclopirox, by Merck Group (1 mentions) Bazedoxifene, by Merck Group (1 mentions) Cytarabine, by Merck Group (1 mentions) Fenbendazole, by Merck Group (1 mentions) Vinorelbine, by Merck Group (1 mentions) Tadalafil, by Cayman Chemical (1 mentions) Penfluridol, by Merck Group (1 mentions) Tioconazole, by Merck Group (1 mentions) Emetine, by Cayman Chemical (1 mentions) Pentamidine, by Cayman Chemical (1 mentions) Oxethazaine, by Merck Group (1 mentions) Pitavastatin, by Cayman Chemical (1 mentions)

Spelling variants of this product

Thioridazine hydrochloride (2 citations)

4 protocols using thioridazine

1

Pharmacological Treatments and Irradiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aripiprazole, quinpirole, and haloperidol were purchased from Tocris (Ellisville, MO, USA). A769662 was obtained from LC Laboratories (Woburn, MA, USA). Thioridazine was obtained from Cayman Chemical (Ann Arbor, MI, USA). Irradiation was performed at room temperature by using a 137Cs gamma‐ray source Gammacell 3000 manufactured by Nordion (Ottawa, ON, Canada).
Lee H., Kang S., Sonn J.K, & Lim Y. (2019). Dopamine receptor D2 activation suppresses the radiosensitizing effect of aripiprazole via activation of AMPK. FEBS Open Bio, 9(9), 1580-1588.
+ Open protocol
+ Expand
2

Genetically Targeted Immunization and Metabolite Uptake in Mice

Cited 2 times
Check if the same lab product or an alternative is used in the 5 most similar protocols
Use of B1–8i+/– and B1–8i+/− Jκ–/– genetically targeted BALB/cJ mice was as described35 (link),36 (link). Mice were maintained under specific-pathogen-free conditions and all animal experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. 6- to 12- week-old mice were immunized i.p. with 50 μg of NP-CGG precipitated in alum to induce GCBCs or NP-Ficoll (Biosearch Technologies) in PBS to induce in vivo activated B cells. Mice were i.p. injected once a day at d9 and d13 post NP-CGG immunization with 22 mg/kg bodyweight Etomoxir (Cayman Chemicals) in 5% DMSO in PBS and 11 mg/kg Thioridazine (Cayman Chemicals) in 0.9% NaCl solution. For in vivo metabolite uptake experiments mice were injected intravenously with 0.171 mg (500 nmol) 2-NBDG (in PBS) or 50 μg BODIPYTM FL C16 (in 2.5% DMSO in PBS) and sacrificed 35 or 60 min later, respectively.
Weisel F.J., Mullett S.J., Elsner R.A., Menk A.V., Trivedi N., Luo W., Wikenheiser D., Hawse W.F., Chikina M., Smita S., Conter L.J., Joachim S.M., Wendell S.G., Jurczak M.J., Winkler T.H., Delgoffe G.M, & Shlomchik M.J. (2020). Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nature immunology, 21(3), 331-342.
+ Open protocol
+ Expand
3

Genetically Targeted Immunization and Metabolite Uptake in Mice

Cited 2 times
Check if the same lab product or an alternative is used in the 5 most similar protocols
Use of B1–8i+/– and B1–8i+/− Jκ–/– genetically targeted BALB/cJ mice was as described35 (link),36 (link). Mice were maintained under specific-pathogen-free conditions and all animal experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. 6- to 12- week-old mice were immunized i.p. with 50 μg of NP-CGG precipitated in alum to induce GCBCs or NP-Ficoll (Biosearch Technologies) in PBS to induce in vivo activated B cells. Mice were i.p. injected once a day at d9 and d13 post NP-CGG immunization with 22 mg/kg bodyweight Etomoxir (Cayman Chemicals) in 5% DMSO in PBS and 11 mg/kg Thioridazine (Cayman Chemicals) in 0.9% NaCl solution. For in vivo metabolite uptake experiments mice were injected intravenously with 0.171 mg (500 nmol) 2-NBDG (in PBS) or 50 μg BODIPYTM FL C16 (in 2.5% DMSO in PBS) and sacrificed 35 or 60 min later, respectively.
Weisel F.J., Mullett S.J., Elsner R.A., Menk A.V., Trivedi N., Luo W., Wikenheiser D., Hawse W.F., Chikina M., Smita S., Conter L.J., Joachim S.M., Wendell S.G., Jurczak M.J., Winkler T.H., Delgoffe G.M, & Shlomchik M.J. (2020). Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nature immunology, 21(3), 331-342.
+ Open protocol
+ Expand
4

Catalog of Diverse Chemical Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Individual chemicals, i.e., albendazole, alexidine, azelastine, bosutinib, carmofur, cladribine, digoxigenin, dronedarone, emetine, miconazole, pentamidine, pitavastatin, sertraline, solifenacin, sulcanozole, tadalafil, terfenadine, thioridazine, trifluorothymidine, and toremifene were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). Additionally, 10-deacetylbaccatin, allyl-thiourea, aminoacridine, bazedoxifene, cephalomannine, cetrimonium bromide, ciclopirox, clomifene, cytarabine, fenbendazole, ouabain, oxethazaine, penfluridol, pyrithione zinc, tioconazole, thioguanine, and vinorelbine were purchased from Sigma-Aldrich. Flubendazole was purchased from LKT Laboratories, Inc. (St. Paul, MN, USA), and gemcitabine and niclosamide were purchased from AdipoGen® Life Science (Liestal, Switzerland), whereas thonzonium bromide and pralatrexate were purchased from MedChemExpress (Monmouth Junction, NJ, USA).
Dell’Anno I., Melani A., Martin S.A., Barbarino M., Silvestri R., Cipollini M., Giordano A., Mutti L., Nicolini A., Luzzi L., Aiello R., Gemignani F, & Landi S. (2022). A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma. Cancers, 14(10), 2527.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!